latest news releases from the newsroom
Ahold Trading Statement -- Third Quarter 2005
AMSTERDAM, Netherlands, Oct. 27, 2005 (PRIMEZONE) -- Ahold today announced consolidated net sales (excluding VAT) of EUR 10.2 billion for the third quarter of 2005 (12 weeks: July 18, 2005 -- October 9, 2005), an increase of 0.7% compared to the same period last year (Q3 2004: EUR 10.2 billion). Net sales, excluding currency impact, increased by 0.3% in the third quarter of 2005.
MorphoSys Reports Nine Months 2005 Results
MARTINSRIED, Germany, Oct. 27, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) today reported financial results according to IFRS for the first nine months ended September 30, 2005.
MorphoSys Appoints Dr. Marlies Sproll as Chief Scientific Officer and Member of the Management Board
MARTINSRIED, Germany, Oct. 27, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) today announced the appointment of Dr. Marlies Sproll (47) as Chief Scientific Officer and a member of its Management Board. The appointment will take effect on November 1, 2005. Dr. Sproll will lead MorphoSys's departments of research and development, as well as alliance management. Dr. Sproll brings to the job more than 15 years of experience in antibody research and discovery, target validation, and pre-clinical and clinical development of biologicals. Before joining MorphoSys, Dr. Sproll worked for seven years at the Vienna research facility of Boehringer Ingelheim. After initially being employed as laboratory head, she later took over international project management for several development projects of therapeutic antibodies as well as antibody conjugates and vaccines in the field of oncology. From 1988 to 1993, Dr. Sproll was lab leader at Merck KGaA in Darmstadt, Germany, where she was involved in the pre-clinical development of therapeutic antibodies.
Glancy Binkow & Goldberg LLP
Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Refco, Inc., Announces Class Action Lawsuit And Seeks to Recover Losses -- RFX
LOS ANGELES, Oct. 26, 2005 (PRIMEZONE) -- Notice is hereby given by Glancy Binkow & Goldberg LLP that a Class Action lawsuit was filed in the United States District Court for the Southern District of New York on behalf of a class (the "Class") consisting of all persons or entities who purchased or otherwise acquired securities of Refco, Inc. ("Refco" or the "Company")(NYSE:RFX) between August 11, 2005 and October 18, 2005, inclusive (the "Class Period") including those who purchased the common stock of Refco pursuant and/or traceable to the Company's initial public offering on August 11, 2005.
Beverly Hills Aesthetics
Beverly Hills Aesthetics' New Mini Facelift Wipes Away 10 Years
BEVERLY HILLS, Calif., Oct. 26, 2005 (PRIMEZONE) -- "The trend in non-surgical cosmetic services is moving away from aggressive reconstruction and going for a more subtle, progressive change in a person's appearance," says Dr. Sam Assassa of Beverly Hills Aesthetics. "Going 'under the knife' is history. Non-invasive procedures, as an alternative to traditional surgical
Enbridge Energy Partners, L.P.
Enbridge Energy Partners Declares Cash Distribution and Reports 2005 Third Quarter Results
HOUSTON, Oct. 26, 2005 (PRIMEZONE) -- Enbridge Energy Partners, L.P. (NYSE:EEP) ("Enbridge Partners" or "the Partnership") today declared a cash distribution of $0.925 per unit payable November 14, 2005 to unitholders of record on November 3, 2005. The Partnership also reported a net loss for the three months ended September 30, 2005 of $(14.4) million, or $(0.32) per unit, compared with net income of $27.6 million, or $0.39 per unit, for the third quarter of the prior year.